Clinical trial

Residual Exacerbations With Mepolizumab

NCT04578171

StatusRECRUITING

Study typeOBSERVATIONAL

Start date2021-07-06

PhaseN/A

Study timeline

Study start (actual)2021-07-06Date precision: day

Registry last updated2025-02-10

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Asthmaunresolved

Interventions

MepolizumabDRUG

Sponsors & collaborators

Laval Universitylead sponsor

GlaxoSmithKlinecollaborator

Mapped research locations

QuébecQuebec, Canada1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04578171 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.